Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
Clinical trial NCT03541668 · COMPLETED
Trial details
- NCT number
- NCT03541668
- Sponsor
- Tasly Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-18
- Primary completion
- 2020-04-14
- Enrollment
- 674
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.